Reddit Posts
10 Best Biotech Penny Stocks To Buy Now ($PSTI, $CLRB and more)
Biotech Penny Stocks & Potential Catalysts This Week - $ALZN $XFOR $MBIO $CLRB $RSLS
Need some help over here at CLRB. 43% owned by institutions. No bad news but tanking come help out
Price Target of $10 for $CLRB / Up 10% Today
[DD] Cancer-B-Gone, or: A look at $CLRB's catalysts & huge institutional buyings
[DD] Everyone hates Cancer, or: Biopharma $CLRB got insane institutional backing in the past 48hrs. What does that mean?
Mentions
CLRB Jumping out of nowhere
Um, all I've got is bags. BYND, SIDU, CLRB, LODE,
ATYR, ACHV, CLRB, -- gamble NWBO
CLRB. anticipates conditional approval from Europe between late Q3 and early Q4. Furthermore, if a partnership is secured to raise additional capital and initiate Phase 3 trials, accelerated approval in the U.S. could also be expected. Despite having received both BTD and PRIME designations and delivering oral presentations at prestigious conferences, its current market cap is only $15 million.
Not to beat a dead broken record which is correct once a day, but biotech stock CLRB is worth a look.
WINT FDMT CLRB all supposed to release data today, guessing it will come after hours
CLRB - Low float and high off market short interest. Phase 2B results come tomorrow.
I’m looking at CLRB rn
$CLRB EMA expected this week
This might have fizzled..but it doesn't really seem like its developed. Where was the pump? I haven't seen any tweets, right-wing influencers pushing it, DJR on the media circuit or anything of the sort. So far all they've done is bring GAG to market via CLRB>PEW. I'm holding shares and my options don't expire until August anyway. Let's see if they pump and dump this. I'm holding, paper hands.
CLRB was clearly on the board few days back. Why was it allowed then and not now?Good job turning this into a political debacle. Now it boils down to freedom of speech and 2A.
scroll down to kk's july 1st last comment of the day. I believe that's why they are trying to squash every CLRB discussion [https://www.reddit.com/user/kk7766/](https://www.reddit.com/user/kk7766/)
Here is another deleted CLRB thread [https://www.reddit.com/r/wallstreetbets/comments/1lwgo13/comment/n2dylgc/](https://www.reddit.com/r/wallstreetbets/comments/1lwgo13/comment/n2dylgc/)
Becomes PEW on Wednesday. Still CLRB Tomorrow on Friday, Monday and Tuesday.
The CLRB to PEW play could be legendary but it smells more like a completely neutral movement
Hold CLRB, SIDU, LODE
Here are some stock I own that have some stuff coming up. Honesty they have all consistently disappointed me and will probably be bad buys. But I'm just looking for others (suckers) to join me in my suffering. 1. Ocugen (OCGN ≈ $1.08) – Monday, June 30 What’s coming: The Phase 3 OCU400 gene-therapy trial (NCT 06388200) reaches its primary completion date on June 30. Sponsors usually issue a status or “last-patient-last-visit” update within a few days of the milestone. fdaaa.trialstracker.net Bonus pressure: June 30 is also the end of Ocugen’s 180-day Nasdaq grace period to get its bid back above $1. Management can either announce compliance (if the Friday/Monday closes average ≥ $1) or say they’ll seek a second 180-day extension or a reverse split. Ocugen was removed from the Russell 1000/3000 on June 27th. ir.ocugen.com 2. Adial Pharmaceuticals (ADIL ≈ $0.46) – Tuesday, July 29 What’s coming: FDA End-of-Phase-2 meeting for AD04, its oral therapy for alcohol-use disorder. The company has already filed the briefing package; the agency meeting is locked in for July 29. Expect a same-day or next-day press release summarizing FDA feedback. adial.com nasdaq.com 3. Cellectar Biosciences (CLRB ≈ $0.88) – “Late July” What’s coming: The EMA has said it will give formal guidance in late July on whether Cellectar’s iopofosine-I-131 Phase 2 data are strong enough for a conditional marketing authorization filing in Waldenström macroglobulinemia. A positive read-through would de-risk the European strategy and usually sparks volume. cellectar.com stocktitan.net 4. AgEagle Aerial Systems (UAVS ≈ $1.08) – Early July watchlist What’s coming: Policy catalyst: AgEagle has now been invited twice to White House roundtables on the forthcoming FAA Part 108 BVLOS rule. Industry lobbyists expect the draft rule to be published “early summer,” and trade press keeps pointing to early-to-mid July for release. If the NPRM drops, every BVLOS-exposed drone stock (UAVS, DPRO, ONDS) tends to pop. globenewswire.com barchart.com Hard date: Q2 earnings are projected for Tuesday, Aug 12; the company’s last two calls went live pre-market. marketbeat.com Near-term PR cadence: AgEagle has been issuing weekly international-sales updates (100th drone in South Korea last week). More “small but frequent” contract PRs are likely. nasdaq.com 5. Kopin (KOPN ≈ $1.61) – Next week What’s coming: Kopin just wrapped its booth at Laser World of Photonics (Munich, Jun 24-27) and historically issues a post-show release within a few trading days highlighting new design wins. Watch Monday/Tuesday for that follow-up. businesswire.com Ongoing driver: The company’s AI-enabled NeuralDisplay™ prototype hit key milestones on June 25—any customer-name drop or defense design-win PR could land during its current road-show circuit. finance.yahoo.com Quick takeaways Most time-certain catalyst: OCGN’s June 30 trial milestone (and separate listing-compliance deadline) is the one you flagged—expect some form of 8-K or press release within 24-48 h. Highest binary risk/reward: ADIL and CLRB events both hinge on regulatory feedback; sparks can cut both ways, so size positions accordingly. Momentum plays: UAVS and KOPN rely more on policy or partner news than single FDA-style binary events, so moves may be smaller but can trend on successive headlines. As always, catalysts ≠ guarantees!
Sorry I meant CLRB
Anyone holding CLRB? I remember someone making a prediction about a target, but can't seem to find it in my notes. I know I have to make my own decisions, but I'm just learning so i'm taking all the free help i can get!
Is CLRB gonna go back up, in at 40 cents
I don't have the knowledge to evaluate the company but one of things I wonder is what the market would be if it succeeds. One of its candidate drugs depends on actinium-225 which is super-expensive, has a very short shelf-life (because it radioactively deteriorates - 10 day half-life) and is in very short supply. There are efforts independently of CLRB to increase supply and decrease cost, but I wonder if in the most optimistic case this drug would ever sell more than a few 1000 doses a year - and it would need to work VERY well to justify the cost. People who follow the company and the company itself must have done the math to analyze how profitable it might be, but I'd like to see it. Targeting treatments (customized to the patient and to the disease) sounds like great medicine, but this ain't gonna be a product on every drug store shelf. More about Actinium here (from one of the very few companies that sell the stuff) [https://www.cnl.ca/health-science-2/actinium-225/](https://www.cnl.ca/health-science-2/actinium-225/)
CLRB, RLYB, SILO, BURU, AND LAES in other words - i have no idea what i'm doing and i'm desperate hahah
CLRB - execution of existing warrants 0.30, about 8.3mil shares. Expected to complete tomorrow, raise about 2.5mil. I will be adding on the dip slowly
I’m going CLRB today. Hopefully it jumps again. Bought in at .5012 🤞🏼
CLRB - some DD, high risk high reward? Yesterday catalyst and news; https://www.stocktitan.net/news/CLRB/cellectar-granted-u-s-fda-breakthrough-therapy-designation-for-h8260vv9qqlf.html https://finance.yahoo.com/news/whats-behind-cellectar-biosciences-stock-163508324.html In summary they currently have the following; *FDA fast track designation *Orphan drug designation *Breakthrough therapy designation (as of yesterday) The above not including European Medicines Agency (EMA), in reviewing for Conditional Marketing Authorisation (decision expected late of July) Stock price tanked in Q3/Q4 2024? https://finance.yahoo.com/news/cellectar-biosciences-stock-plunges-cancer-162502647.html First Quarter 2025 financial and corporate update. https://www.cellectar.com/news-media/press-releases/detail/358/cellectar-biosciences-reports-first-quarter-2025-financial *Explore full range of strategic alternatives, has engaged Oppenheimer as strategic evaluation process. Translation, CLRB shopping for partner or buyer. *Phase 3 trial dependent upon the company obtaining additionl funding or strategic collaboration which are the above. Translation, they can execute but waiting for partnership or buyout. AdditionallyC they may seek additional extension beyond July 29 if they *Cash available until fourth quarter 2025, for basic operations. What is the risk? High risk high reward? https://investor.cellectar.com/all-sec-filings/content/0001104659-25-040241/tm2512660-4_def14a.htm?TB_iframe=true&height=auto&width=auto&preload=false#ya_012 Jun 13th shareholder meeting and one of it is vote for Reverse Split. The keyword “considering alternatives to the proposed reverse split”. It is also possible for them to seek for 2nd extension provided they meet Nasdaq requirements, it was mentioned on the 2nd paragraph below. “We are currently considering alternatives to the proposed reverse stock split. However, if such alternatives do not have the effect of allowing the Company to regain compliance with the Nasdaq Capital Market’s minimum bid price requirement, we intend to effect the reverse stock split to regain compliance.” “On January 30, 2025, we received a deficiency letter from the Nasdaq Stock Market notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum bid price. In accordance with Nasdaq rules, the Company was provided an initial period of 180 calendar days, or until July 29, 2025, to regain compliance. The Company intends to seek an extension from Nasdaq. If the Company does not regain compliance with the minimum bid price rule, Nasdaq will provide written notification to the Company that its common stock may be delisted.” My takes; *Pre-Phase 3 Buyout is Highly Plausible *Strong Phase 2 *Regulatory Fast Track *Shopping for partner/buyer - Oppenheimer CLRB publicly engaged Oppenheimer & Co. in May 2025 to explore: • Mergers • Acquisitions • Licensing/partnerships • This is a formal, active sale process — not speculation I’m smelling buyout? Yes, I still have my share with cost at 0.34x! 100mil, price per share 6.x 150mil, price per share 9.x 200mil, price per share 12.x 250mil, price per share 15.x
Huh? I made bank on CLRB today.
Not CLBR, but CLRB...any questions?
CLRB says 0 shares left to short on Fintel
CLRB going for a cheeky pump again?
CLRB not really a squeeze since its getting FDA approval
I really hope one of you regards accidentally bought CLRB instead of CLBR and now find yourself up 90%
We should have known CLRB sooner, was worth 50% today. I am sad. I am gonna take my 10% on it cause its risky.
https://preview.redd.it/79qsh97w0x4f1.jpeg?width=1014&format=pjpg&auto=webp&s=f0d3bca9c2c8fef8e58fed2f935668895b993b67 CLRB pumping
I was waiting for an entry on CLRB at .37 and it shot up … sigh 😞
HSCS with FDA news like CLRB, in case you’re too late for the CLRB one. HSCS: https://www.stocktitan.net/news/HSCS/heart-sciences-receives-fda-breakthrough-device-designation-for-myo-c9zg5ewuzhs2.html
CLRB just announced FDA related news
CLRB looks interesting with their news
Glad we can finally shut up about CLRB... was so annoying to see the massive spam posts and the YOLOs.. YOLO back to WEndys
Ironically, the best advice right now is for CLRB baggies to NOT GrabAGun
Add a headstone for CLRB next WISH
CLRB probably going up again soon too… calls
CLRB call/put ratio is fucking insane
CLRB just finished a great conference. Has jumped 5% in a couple mins get in early
CLRB hasn’t submitted anything to FDA to get the ball rolling in their pipeline. They will probably have to RS to stay current with Nasdaq listing standards. I’d probably wait on this one.
CLRB could be one to look at. They’re presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Feb 12th
$CLRB - next biotech to have 20-40x bagger potential. Undervalued af right now given all the ridiculous radio pharma exits ($ryze, $fusn). Pivotal phase 2 asset about to get approved by the fda. Just so you know their phase 2 data cleared fda requirements for major responses rates by over 100%. Get in and ride it
Anyone following CLRB biostock with me ?
!banbet CLRB 3 17d
Got it on CLRB. New trader that hasn’t been doing too well. This is the week it turns around for me. We’re all gonna make some money!
CLRB is looking at a huge potential payoff. News coming in a few days which will be a major catalyst. BUY BUY BUY! Bullish biotech company ready to explode
CLRB will publish their pivotal data early Jan. In March, they will apply to FDA. Then around Sept 2024 if they get approval from FDA the stock will sky rocket.
This was a mix of biotech stocks and some random follow the hype stocks. When I first started trading I bought into bpmx which is now after many reverse splits $TMBR and also bought into $AUPH. Bought in $GSL cause some random thread somewhere said go buy $GSL. Also reverse split like the olympics before I closed out. Was trading a lot of 3xETFs like $JNUG and $JDST. Some other randos I lost on: $HEB $DCTH $STAF $CLRB $DARE My final 8k loss was on a ARKF call
I'm holding Cellectar Biosciences ($CLRB). They are currently through Pivotal Trial, which has yielded positive results thus far. They've been given orphan status as well as FDA Fast Track status.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: CLRB. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
I'm holding $CLRB - Cellectar Biosciences.
CLRB, once their cancer treatment gets approved their stock will go significantly up
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: CLRB. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
Must be something I'm massively missing because it shows up in the ticker symbols DCTH, TOPS, GOVX, CLRB, EGLE, and more.
I am a bot. You submitted a picture of a banned ticker, CLRB. This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
Still bullish on CLRB
CLRB holds close to my deep soulful heart as it was the very first penny stock I played in 2016. If this low float sexy ticker is going to make a run, I’m excited for my reunion with her!!!!
CLRB currently at 1.11 with avg price target of $6.17, taking my XELA profits and dumping it into this
Cellectar Biosciences Expands Collaboration Deal With South Korea's IntoCell for New Cancer Drugs 7/13/21, 11:11 AM 01:11 PM EDT, 07/13/2021 (MT Newswires) -- Cellectar Biosciences (CLRB) reported Tuesday that it has expanded its collaboration with South Korean biotech firm IntoCell to develop cancer drugs combining their platforms. Their collaboration has exceeded the necessary preclinical results to warrant further development and the initiation of an investigational new-drug application with the US Food and Drug Administration, the late-stage drugmaker said. Cellectar will have the right to globally develop and commercialize any molecules containing phospholipid-drug conjugates. Shares of Cellectar are down more than 3% in midday trading. Price: 1.11, Change: -0.04, Percent Change: -3.48
For anyone who wants to make non meme stock plays,CLRB has results tomorrow at 10am tomorrow and may run up and enphase because powell is talking about green energy🤔
DTGI is holding steady after a very brief dip this morning. I am mainly focused on holding it at ATDS for a few more months. I have a few biotech gambles that are absolutely being crushed, such as CLBS and CLRB, but I am holding onto them too. Inflation worries seem to be one of the big trends right now, and the CPI report tomorrow could send that issue flying even more. Prices have obviously been creeping up on everything, so expect to see a ton of inflation worries for the rest of this year. That's not good for most of these speculative stocks. Hold onto your butts.
UWMC, ATOS, BXRX, CLRB, Bags.
CTXR and OBSV are trying to recover...AGTC and CLRB are asleep on the floor.
Almost every biopharm dropped 3-6% almost immediately today. AGTC, OBSV, CTXR, CLRB and even SURF. SURF crawled back up but the rest are having trouble getting there. I can’t find any reason for it other than someone handed Yellen a microphone this morning. 🤦🏻♂️
CLRB had a 5.59% gain on half its usual average volume hmmm...
$SpCB I was going to say it stop calling it the dash for trash it's the hunt for yield in the interest rate environment that is what it is Here are the advantages you take them or leave long-short portfolio is our leverage in despite what you've been told by your guru hedge funds exclusively on penny stocks especially sub $10 in low floats there's always angry former investors the majority of the time who have lost money there's always aggressive shorts Jim chanos refers to as the the pinata hit and smash chasers or something GameStop in planet fitness and even if fastlys move happened because of the size of the float!!! There's an additional risk if you do foreign names I especially would stay away from Chinese Israelis haven't been as bad but still you really want to go for a well-known NASDAQ name that's what happened with BlackBerry theranos cough cough I mean eyes But you want there to be a story Like data is the new oil Transhumanism bologna At least one or two fundamentals in your favor In the short selling to be leveraged Options are leverage Warrants can even be leveraged $CLRB take a look at the three months chart if you don't believe me No such thing as a gamma squeeze Liquidity event what happened with short-selling plus leverage with people that are utterly convinced that they're right honestly I think even though you should consider being wrong and being open to your thesis changing you should still have that same attitude as well not worried about the butterfly effect or the Black swan second always look at the 5-year chart because even though it's a completely new investors the price actions always still the same and it's maddening The track is letting it happen and not getting it stepping on your own two feet so to speak Overall market conditions matter but not as much as you think they do I hope this helps someone just starting out If not you can deal with blue chips this game isn't for everyone but your not gonna get in the market wizard. Books Side note debunking the coin flip myth they teach you right out of the gate If you don't trade so often then in the first few series of flips tails is break Even or even does better than heads In the long run we're all throwing chimps throwing darts even the professionals food for thought have a good day
CLRB Up front disclosure: yes - I am holding shares of it and here’s why: EU granted them an orphan drug status with 10year exclusivity Japan just recently gave them a patent (patent number 6832861). And their pipeline has some amazing potential. It’s price dipped along with everything else recently but check out the weird AH movement on it (spikes). I had based my initial buy in on the results from clinical studies but then I got curious about the AH price movement as it has been usual on several days. Vanguard bought in and was (maybe still is) holding over a million shares. Several HFs have done the same. Not advising anyone to buy anything — just take a look at it and make your own decision.
CLRB is looking good at 1.99. Japan just recently gave them a patent: https://finance.yahoo.com/news/cellectar-granted-japanese-composition-matter-140000520.html They also received an EU orphan drug designation with 10 years of exclusivity: https://finance.yahoo.com/news/cellectar-receives-orphan-drug-designation-133000625.html
This post mentions: **$ROTH, $DEVV, $CLR, $CLRB, $ONTX, $IMO, $ACCYY** /u/bernie_gursz's account was created **2 years ago**. It has **2597** comment karma and **6017** link karma. ----- ^You ^may ^see ^tickers ^you ^didn't ^mention ^-- ^I'm ^casting ^a ^wide ^net ^because ^y'all ^don't ^always ^$TAG ^your ^ticker ^symbols. ^This ^was ^an ^automated ^response. ^If ^you ^have ^feedback, ^please ^reply ^to ^this ^comment ^or [^(send me a message)](https://www.reddit.com/message/compose?to=RichSteps&subject=bot%20feedback)^.
If I have to count on RYCEY and CLRB to see a little green in my portfolio then you know it's truly a fucked day.
Additional info. These guys partnered with another similar firm a few years ago, $CLRB, with whom they are attending the same event next week. They also have had similar patterns if steep drops in price leading to both earnings on 3/11 and the even next week. Both have lots lots of short shares available to buy.
On /r/pennystocks, /u/Yankeefan1970 has previously mentioned: |||||||| |:-|:-|:-|:-|:-|:-|:- **ticker**|CBD|IPO|FRSX|EPS|CLRB|BBIG **mentions**|2|1|1|1|1|1 /u/Yankeefan1970's account was created **1 month ago**. It has **243** comment karma and **55** link karma. ----- ^(You may see tickers you didn't mention -- I'm casting a wide net because y'all don't always $TAG your ticker symbols.) ^(This was an automated response. If you have feedback, please reply to this comment or) [^(send me a message)](https://www.reddit.com/message/compose?to=RichSteps&subject=bot%20feedback)^.
CLRB is attending the same conference as ASRT. Crazy low price. Seems like the stock has been declining waiting for the conference. Historical stock price is crazy high and I am not knowledgeable enough to decipher it.
Not exactly a penny stock. Chart looks really weak! If it breaks support at $1.90, it is a long way down from there. [https://stockcharts.com/h-sc/ui?s=CLRB](https://stockcharts.com/h-sc/ui?s=CLRB)
Futures are down. Looks like maybe last week's red streak continues today. All my penny positions have become mid to long holds. Nothing really on the table for swing trades at the moment. I'm into TLOFF, CTRM, , CLRB, and AGNPF where I sold my initial investment's worth after they went up to 20% over my core position. So those are just riding. I keep averaging down on TLSS and RSSV. I keep waiting for HITIF to actually do something so I can get out of it. TNXP is the dog of portfolio. I'm still learning to recognize P&Ds, and got taken by this one. My position is small, so I'm just waiting for the next round of pumps to sell, or I'll write it off at a loss as part of my trading education.
Your post with title "OCGN HCMC RBNW MMEX PBHG ZOM CLWD AXXA CLRB ONTX LCKO GNUS" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
Got some CLRB cheap in premarket. Holding and buying more SNPW for another bounce that will come eventually. Also still holding TLSS. Got some ALKM and trying to catch some PURA